Cormorant Asset Management

Cormorant Asset Management as of March 31, 2016

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 84 positions in its portfolio as reported in the March 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Biotie Therapies Corp. ads 66.6 $1.3B 50k 26390.00
Alder Biopharmaceuticals 1.9 $37M 1.5M 24.49
Heron Therapeutics (HRTX) 1.7 $33M 1.8M 18.99
Sage Therapeutics (SAGE) 1.5 $30M 945k 32.06
Omeros Corporation (OMER) 1.5 $30M 2.0M 15.34
Nektar Therapeutics (NKTR) 1.4 $28M 2.0M 13.75
Nevro (NVRO) 1.4 $27M 485k 56.26
Neurocrine Biosciences (NBIX) 1.2 $24M 604k 39.55
Alkermes (ALKS) 1.2 $24M 700k 34.19
Eagle Pharmaceuticals (EGRX) 1.0 $20M 500k 40.50
Dynavax Technologies (DVAX) 0.9 $19M 975k 19.24
Proteostasis Therapeutics In 0.8 $17M 1.7M 9.64
Alnylam Pharmaceuticals (ALNY) 0.8 $15M 245k 62.77
Portola Pharmaceuticals 0.7 $14M 700k 20.40
Quotient 0.7 $13M 1.5M 8.80
Macrogenics (MGNX) 0.7 $13M 700k 18.75
Tesaro 0.7 $13M 291k 44.03
Cellectis S A (CLLS) 0.7 $13M 469k 27.50
China Biologic Products 0.6 $13M 112k 114.48
Aclaris Therapeutics (ACRS) 0.6 $12M 648k 18.95
Coherus Biosciences (CHRS) 0.6 $12M 569k 21.23
Ardelyx (ARDX) 0.6 $12M 1.5M 7.77
Vitae Pharmaceuticals 0.6 $12M 1.7M 6.63
Sorrento Therapeutics (SRNE) 0.6 $11M 2.1M 5.38
Minerva Neurosciences 0.5 $11M 1.8M 6.14
Mirati Therapeutics 0.5 $11M 495k 21.40
Dex (DXCM) 0.5 $10M 153k 67.91
Celgene Corporation 0.5 $10M 100k 100.09
Novavax 0.4 $8.3M 1.6M 5.16
Rockwell Medical Technologies 0.4 $8.3M 1.1M 7.51
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.4 $8.2M 450k 18.15
Myokardia 0.4 $8.1M 753k 10.71
Advaxis 0.4 $7.2M 800k 9.03
Celator Pharmaceuticals 0.3 $6.8M 620k 11.03
Ultragenyx Pharmaceutical (RARE) 0.3 $6.9M 110k 63.31
Lipocine 0.3 $6.8M 667k 10.15
Seres Therapeutics (MCRB) 0.3 $6.6M 250k 26.56
Agenus 0.3 $6.5M 1.6M 4.16
Pfenex 0.3 $6.1M 625k 9.83
Forward Pharma A/s 0.3 $5.7M 335k 17.00
Acceleron Pharma 0.3 $5.3M 200k 26.39
Wave Life Sciences (WVE) 0.3 $5.4M 392k 13.88
Cytomx Therapeutics (CTMX) 0.2 $4.8M 371k 12.90
Recro Pharma 0.2 $4.7M 780k 5.97
Zynerba Pharmaceuticals 0.2 $4.5M 475k 9.45
Achillion Pharmaceuticals 0.2 $3.9M 500k 7.72
Dermira 0.2 $3.5M 170k 20.68
Agile Therapeutics 0.2 $3.5M 557k 6.21
Celyad Sa 0.2 $3.3M 75k 44.16
Intec Pharma 0.2 $3.3M 800k 4.12
Epizyme 0.2 $3.2M 266k 12.12
Kite Pharma 0.2 $3.2M 69k 45.92
Aptose Biosciences 0.2 $3.2M 1.1M 2.94
BioCryst Pharmaceuticals (BCRX) 0.1 $3.1M 1.1M 2.83
Contrafect 0.1 $2.8M 834k 3.40
Bellicum Pharma 0.1 $2.8M 300k 9.35
Atara Biotherapeutics 0.1 $2.9M 150k 19.03
Syndax Pharmaceuticals (SNDX) 0.1 $2.9M 214k 13.32
Lion Biotechnologies 0.1 $2.5M 500k 5.08
Ovascience 0.1 $2.4M 252k 9.49
Epirus Biopharmaceuticals In 0.1 $2.4M 897k 2.69
Immune Design 0.1 $2.5M 189k 13.00
Curis 0.1 $1.9M 1.2M 1.61
Glycomimetics (GLYC) 0.1 $1.7M 284k 5.96
Regenxbio Inc equity us cm (RGNX) 0.1 $1.7M 157k 10.80
Aquinox Pharmaceuticals 0.1 $1.3M 150k 8.82
Amicus Therapeutics (FOLD) 0.1 $1.3M 150k 8.45
Ascendis Pharma A S (ASND) 0.1 $1.1M 62k 18.55
Tetralogic Pharmaceuticals c note 8.000% 6/1 0.1 $1.2M 5.0M 0.23
AVEO Pharmaceuticals 0.1 $1.0M 1.1M 0.92
Genvec 0.1 $953k 1.2M 0.81
Veracyte (VCYT) 0.0 $745k 138k 5.40
Provectus Biopharmaceuticals I (PVCT) 0.0 $836k 2.2M 0.38
Nanostring Technologies (NSTGQ) 0.0 $609k 40k 15.22
Htg Molecular Diagnostics 0.0 $577k 201k 2.87
Neos Therapeutics 0.0 $540k 50k 10.80
Threshold Pharmaceuticals 0.0 $460k 1.0M 0.46
Provectus Biopharmaceuticals *w exp 06/24/202 0.0 $440k 2.2M 0.20
Pronai Therapeutics 0.0 $358k 53k 6.74
Regulus Therapeutics 0.0 $212k 31k 6.92
Applied Genetic Technol Corp C 0.0 $239k 17k 13.97
Adaptimmune Therapeutics (ADAP) 0.0 $203k 25k 8.12
Cellectar Biosciences 0.0 $180k 53k 3.40
Cellectar Biosciences Inc *w exp 08/19/201 0.0 $38k 53k 0.72